BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21331271)

  • 1. Immune therapy for breast cancer in 2010-hype or hope?
    Florescu A; Amir E; Bouganim N; Clemons M
    Curr Oncol; 2011 Jan; 18(1):e9-e18. PubMed ID: 21331271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic approaches for the treatment of breast cancer.
    Knutson KL; Schiffman K; Rinn K; Disis ML
    J Mammary Gland Biol Neoplasia; 1999 Oct; 4(4):353-65. PubMed ID: 10705919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient or methodical review of immunotherapy against breast cancer.
    Guanghui R; Xiaoyan H; Shuyi Y; Jun C; Guobin Q
    J Biochem Mol Toxicol; 2019 Aug; 33(8):e22339. PubMed ID: 31157481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
    Madden DL
    Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines.
    Sanchez K; Page D; McArthur HL
    Curr Probl Cancer; 2016; 40(2-4):151-162. PubMed ID: 27855963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Vaccine Therapies for Breast Cancer.
    Li X; Bu X
    Adv Exp Med Biol; 2017; 1026():315-330. PubMed ID: 29282691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.
    Mohit E; Hashemi A; Allahyari M
    Expert Rev Clin Immunol; 2014 Jul; 10(7):927-61. PubMed ID: 24867051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation of immunotherapy for melanoma.
    Kirkwood JM; Tarhini AA; Panelli MC; Moschos SJ; Zarour HM; Butterfield LH; Gogas HJ
    J Clin Oncol; 2008 Jul; 26(20):3445-55. PubMed ID: 18612161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint Blockade in Breast Cancer Therapy.
    Bu X; Yao Y; Li X
    Adv Exp Med Biol; 2017; 1026():383-402. PubMed ID: 29282694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of Breast Cancer.
    Criscitiello C; Curigliano G
    Prog Tumor Res; 2015; 42():30-43. PubMed ID: 26377084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapies in AML: reason for hope or just hype?
    Larkin K; Blum W
    Am Soc Clin Oncol Educ Book; 2014; ():e341-51. PubMed ID: 24857123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in Breast Cancer.
    Marmé F
    Oncol Res Treat; 2016; 39(6):335-45. PubMed ID: 27260697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibody for cancer treatment].
    Achiwa H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.
    Ashraf Y; Mansouri H; Laurent-Matha V; Alcaraz LB; Roger P; Guiu S; Derocq D; Robin G; Michaud HA; Delpech H; Jarlier M; Pugnière M; Robert B; Puel A; Martin L; Landomiel F; Bourquard T; Achour O; Fruitier-Arnaudin I; Pichard A; Deshayes E; Turtoi A; Poupon A; Simony-Lafontaine J; Boissière-Michot F; Pirot N; Bernex F; Jacot W; du Manoir S; Theillet C; Pouget JP; Navarro-Teulon I; Bonnefoy N; Pèlegrin A; Chardès T; Martineau P; Liaudet-Coopman E
    J Immunother Cancer; 2019 Feb; 7(1):29. PubMed ID: 30717773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy.
    Galván Morales MA; Barrera Rodríguez R; Santiago Cruz JR; Teran LM
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33276556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer.
    Sivaganesh V; Promi N; Maher S; Peethambaran B
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for breast cancer: past, present, and future.
    Spellman A; Tang SC
    Cancer Metastasis Rev; 2016 Dec; 35(4):525-546. PubMed ID: 27913998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.